Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck have?
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck has 5,125 citations in the OpenAlex counts ScholarIQ stores.
When was Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck published?
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck has 2016 year in the ScholarIQ index.
What is the open-access status of Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck?
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck has bronze oa status in the ScholarIQ index.
What is the DOI of Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck?
The DOI for Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck is on the source record.
What is the PMID of Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck?
The PMID for Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck is on the source record.
What is the OpenAlex record for Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck?
The OpenAlex for Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck is on the source record.